Enhancing future liver remnant hypertrophy: innovative preoperative strategies and emerging technologies
Open Access
- 1 May 2026
- journal article
- review article
- Published by AME Publishing Company in Translational Gastroenterology and Hepatology
- Vol. 11, 73
Abstract
Major hepatectomy remains the only curative option for many primary and secondary liver malignancies, yet postoperative liver failure continues to limit resectability when the future liver remnant (FLR) is insufficient. Over recent decades, a spectrum of strategies has been developed to safely enlarge and optimize FLR volume and function. This review summarizes established and emerging approaches aimed at enhancing preoperative FLR hypertrophy. Conventional methods such as portal vein embolization (PVE) and portal vein ligation (PVL) remain first-line techniques, while associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) achieves rapid but riskier hypertrophy. Liver venous deprivation (LVD) and combined strategies—including transarterial chemoembolization (TACE) plus PVE or radioembolization—offer faster or dual oncologic-regenerative benefits with improved safety profiles. Innovative developments such as pharmacologic modulation [farnesoid X receptor (FXR), FGF19, THR-β, and GLP-1 agonists], growth factor delivery, and stem-cell-based therapies are emerging to enhance both volumetric and functional regeneration, particularly in steatotic or fibrotic livers. Advanced imaging and predictive technologies—such as 99mTc-mebrofenin hepatobiliary scintigraphy (HBS), four-dimensional (4D)-flow magnetic resonance imaging (MRI), and computed tomography (CT)-based radiomics—enable integrated volumetric-functional assessment and individualized surgical timing. Although PVE remains the benchmark, multimodal, patient-tailored strategies combining hemodynamic, pharmacologic, and cellular interventions, guided by functional imaging, are reshaping the landscape of hepatic surgery. Future randomized trials and translational studies are essential to define optimal algorithms, validate novel therapies, and safely extend curative resection to a broader population of patients with complex liver disease.Keywords
This publication has 117 references indexed in Scilit:
- Identification of cofactors influencing hypertrophy of the future liver remnant after portal vein embolization—the effect of collaterals on embolized liver volumeBritish Journal of Radiology, 2016
- Percutaneous Microwave Ablation Liver Partition and Portal Vein Embolization for Rapid Liver RegenerationAnnals of Surgery, 2016
- Portal vein embolization for induction of selective hepatic hypertrophy prior to major hepatectomy: rationale, techniques, outcomes and future directionsCancer Biology & Medicine, 2016
- Comparison of techniques for volumetric analysis of the future liver remnant: implications for major hepatic resectionsHPB, 2015
- Contra-lateral liver lobe hypertrophy after unilobar Y90 radioembolization: An alternative to portal vein embolization?World Journal of Gastroenterology, 2015
- Portal vein embolization effect on colorectal cancer liver metastasis progression: Lessons learnedWorld Journal of Clinical Oncology, 2015
- Liver remnant hypertrophy induction – How often do we really use it in the time of computer assisted surgery?Advances in Medical Sciences, 2012
- Tumor Progression After Preoperative Portal Vein EmbolizationAnnals of Surgery, 2012
- Preoperative Y-90 microsphere selective internal radiation treatment for tumor downsizing and future liver remnant recruitment: a novel approach to improving the safety of major hepatic resectionsWorld Journal of Surgical Oncology, 2009
- Portal Vein Ligation as an Efficient Method of Increasing the Future Liver Remnant Volume in the Surgical Treatment of Colorectal MetastasesArchives of Surgery, 2008